Mary McElroy, PhD

Dr. Mary McElroy is Associate Director of Discovery Toxicology and Pharmacology at Charles River Laboratories. In this capacity, Mary’s team run a range of in vivo lung pharmacology models and in vitro safety assessments studies including lung organotypic cultures for human relevant risk assessment by inhalation route.  Prior to Charles River, Mary spent her career performing lung-related cell-biology, pharmacology, and toxicology. Mary has an MSc in Toxicology from University of Surrey, PhD in Human Lung Development from the University of Southampton, post-doctoral research on alveolar epithelial cell biology at University of California San Francisco, Lecturer/Group Leader positions at the Trinity Collage Dublin and University of Edinburgh.  Mary is a European Registered Toxicologist and holds an MBA from the Open University.